Literature DB >> 27069549

Wide-ranging alterations in the brain fatty acid complement of subjects with late Alzheimer's disease as detected by GC-MS.

Muhammad Luqman Nasaruddin1, Christian Hölscher2, Patrick Kehoe3, Stewart Francis Graham4, Brian Desmond Green1.   

Abstract

Disturbed lipid metabolism is a well-established feature of human Alzheimer's disease (AD). The present study used gas chromatography-mass spectrometry (GC-MS) analysis of fatty acid methyl esters (FAMES) to profile all detectable fatty acid (FA) species present in post-mortem neocortical tissue (Brodmann 7 region). Quantitative targeted analysis was undertaken from 29 subjects (n=15 age-matched controls; n=14 late-stage AD). GC-MS analysis of FAMES detected a total of 24 FAs and of these, 20 were fully quantifiable. The results showed significant and wide ranging elevations in AD brain FA concentrations. A total of 9 FAs were elevated in AD with cis-13,16-docosenoic acid increased most (170%; P=0.033). Intriguingly, docosahexanoic acid (DHA; C22:6) concentrations were elevated (47%; P=0.018) which conflicts with the findings of others (unaltered or decreased) in some brain regions after the onset of AD. Furthermore, our results appear to indicate that subject gender influences brain FA levels in AD subjects (but not in age-matched control subjects). Among AD subjects 7 FA species were significantly higher in males than in females. These preliminary findings pinpoint FA disturbances as potentially important in the pathology of AD. Further work is required to determine if such changes are influenced by disease severity or different types of dementia.

Entities:  

Keywords:  AD; DHA; Fatty acid; GC-MS; brain tissues

Year:  2016        PMID: 27069549      PMCID: PMC4759425     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  50 in total

Review 1.  Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers.

Authors:  Charles N Serhan; Makoto Arita; Song Hong; Katherine Gotlinger
Journal:  Lipids       Date:  2004-11       Impact factor: 1.880

Review 2.  Lipidomics: potential role in risk prediction and therapeutic monitoring for diabetes and cardiovascular disease.

Authors:  Peter J Meikle; Gerard Wong; Christopher K Barlow; Bronwyn A Kingwell
Journal:  Pharmacol Ther       Date:  2014-02-06       Impact factor: 12.310

Review 3.  Amyloid-β and tau--a toxic pas de deux in Alzheimer's disease.

Authors:  Lars M Ittner; Jürgen Götz
Journal:  Nat Rev Neurosci       Date:  2010-12-31       Impact factor: 34.870

Review 4.  Polyunsaturated fatty acids, neuroinflammation and well being.

Authors:  Sophie Layé
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2010-03-15       Impact factor: 4.006

5.  Investigation of the human brain metabolome to identify potential markers for early diagnosis and therapeutic targets of Alzheimer's disease.

Authors:  Stewart F Graham; Olivier P Chevallier; Dominic Roberts; Christian Hölscher; Christopher T Elliott; Brian D Green
Journal:  Anal Chem       Date:  2013-01-08       Impact factor: 6.986

6.  Fatty acid composition of frontal, temporal and parietal neocortex in the normal human brain and in Alzheimer's disease.

Authors:  Thomas Fraser; Hannah Tayler; Seth Love
Journal:  Neurochem Res       Date:  2009-11-11       Impact factor: 3.996

7.  Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease.

Authors:  Lesley Jones; Peter A Holmans; Marian L Hamshere; Denise Harold; Valentina Moskvina; Dobril Ivanov; Andrew Pocklington; Richard Abraham; Paul Hollingworth; Rebecca Sims; Amy Gerrish; Jaspreet Singh Pahwa; Nicola Jones; Alexandra Stretton; Angharad R Morgan; Simon Lovestone; John Powell; Petroula Proitsi; Michelle K Lupton; Carol Brayne; David C Rubinsztein; Michael Gill; Brian Lawlor; Aoibhinn Lynch; Kevin Morgan; Kristelle S Brown; Peter A Passmore; David Craig; Bernadette McGuinness; Stephen Todd; Clive Holmes; David Mann; A David Smith; Seth Love; Patrick G Kehoe; Simon Mead; Nick Fox; Martin Rossor; John Collinge; Wolfgang Maier; Frank Jessen; Britta Schürmann; Reinhard Heun; Heike Kölsch; Hendrik van den Bussche; Isabella Heuser; Oliver Peters; Johannes Kornhuber; Jens Wiltfang; Martin Dichgans; Lutz Frölich; Harald Hampel; Michael Hüll; Dan Rujescu; Alison M Goate; John S K Kauwe; Carlos Cruchaga; Petra Nowotny; John C Morris; Kevin Mayo; Gill Livingston; Nicholas J Bass; Hugh Gurling; Andrew McQuillin; Rhian Gwilliam; Panos Deloukas; Ammar Al-Chalabi; Christopher E Shaw; Andrew B Singleton; Rita Guerreiro; Thomas W Mühleisen; Markus M Nöthen; Susanne Moebus; Karl-Heinz Jöckel; Norman Klopp; H-Erich Wichmann; Eckhard Rüther; Minerva M Carrasquillo; V Shane Pankratz; Steven G Younkin; John Hardy; Michael C O'Donovan; Michael J Owen; Julie Williams
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

8.  Palmitic acid increases apoptosis of neural stem cells via activating c-Jun N-terminal kinase.

Authors:  Qiuhuan Yuan; Shidou Zhao; Fuwu Wang; Hui Zhang; Zi-Jiang Chen; Juntao Wang; Zhen Wang; Zhaoxia Du; Eng-Ang Ling; Qian Liu; Aijun Hao
Journal:  Stem Cell Res       Date:  2012-12-09       Impact factor: 2.020

Review 9.  Protein-lipid interactions and phosphoinositide metabolism in membrane traffic: insights from vesicle recycling in nerve terminals.

Authors:  Markus R Wenk; Pietro De Camilli
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-14       Impact factor: 11.205

10.  Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.

Authors:  W S Griffin; L C Stanley; C Ling; L White; V MacLeod; L J Perrot; C L White; C Araoz
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

View more
  15 in total

1.  Recent Advances in Understanding of Alzheimer's Disease Progression through Mass Spectrometry-Based Metabolomics.

Authors:  Jericha Mill; Lingjun Li
Journal:  Phenomics       Date:  2022-02-22

2.  Reactive Thread Spray Mass Spectrometry for Localization of C═C Bonds in Free Fatty Acids: Applications for Obesity Diagnosis.

Authors:  Devin J Swiner; Dmytro S Kulyk; Hannah Osae; George R Durisek Iii; Abraham K Badu-Tawiah
Journal:  Anal Chem       Date:  2022-01-24       Impact factor: 8.008

3.  Nuclear Receptors as Therapeutic Targets for Neurodegenerative Diseases: Lost in Translation.

Authors:  Miguel Moutinho; Juan F Codocedo; Shweta S Puntambekar; Gary E Landreth
Journal:  Annu Rev Pharmacol Toxicol       Date:  2018-09-12       Impact factor: 13.820

Review 4.  Systems healthcare: a holistic paradigm for tomorrow.

Authors:  Massimo S Fiandaca; Mark Mapstone; Elenora Connors; Mireille Jacobson; Edwin S Monuki; Shaista Malik; Fabio Macciardi; Howard J Federoff
Journal:  BMC Syst Biol       Date:  2017-12-19

5.  Oligomeric amyloid-beta induces MAPK-mediated activation of brain cytosolic and calcium-independent phospholipase A2 in a spatial-specific manner.

Authors:  Juan Pablo Palavicini; Chunyan Wang; Linyuan Chen; Kristen Hosang; Jianing Wang; Takami Tomiyama; Hiroshi Mori; Xianlin Han
Journal:  Acta Neuropathol Commun       Date:  2017-07-27       Impact factor: 7.801

Review 6.  Significance of long chain polyunsaturated fatty acids in human health.

Authors:  Rafael Zárate; Nabil El Jaber-Vazdekis; Noemi Tejera; José A Pérez; Covadonga Rodríguez
Journal:  Clin Transl Med       Date:  2017-07-27

7.  Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: A nontargeted metabolomic study.

Authors:  Stuart G Snowden; Amera A Ebshiana; Abdul Hye; Yang An; Olga Pletnikova; Richard O'Brien; John Troncoso; Cristina Legido-Quigley; Madhav Thambisetty
Journal:  PLoS Med       Date:  2017-03-21       Impact factor: 11.069

8.  Free Fatty Acids Are Associated with the Cognitive Functions in Stroke Survivors.

Authors:  Dariusz Kotlęga; Barbara Peda; Joanna Palma; Agnieszka Zembroń-Łacny; Monika Gołąb-Janowska; Marta Masztalewicz; Przemysław Nowacki; Małgorzata Szczuko
Journal:  Int J Environ Res Public Health       Date:  2021-06-16       Impact factor: 3.390

9.  Metabolomic Profiling of Bile Acids in Clinical and Experimental Samples of Alzheimer's Disease.

Authors:  Xiaobei Pan; Christopher T Elliott; Bernadette McGuinness; Peter Passmore; Patrick G Kehoe; Christian Hölscher; Paula L McClean; Stewart F Graham; Brian D Green
Journal:  Metabolites       Date:  2017-06-17

10.  Evidence That Parietal Lobe Fatty Acids May Be More Profoundly Affected in Moderate Alzheimer's Disease (AD) Pathology Than in Severe AD Pathology.

Authors:  Muhammad L Nasaruddin; Xiaobei Pan; Bernadette McGuinness; Peter Passmore; Patrick G Kehoe; Christian Hölscher; Stewart F Graham; Brian D Green
Journal:  Metabolites       Date:  2018-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.